Codevelopped by Cryocath and the MHI

Guided by the expertise of Cardiologist Dr. Marc Dubuc

Significant technology breakthrough sold worldwide

The Arctic Front Cryoablation balloon is a simple alternative to the radio frequency technique typically used to isolate pulmonary veins.

It is the only non thermal ablation catheter available on the market designed to treat atrial fibrilation.

The second generation of the world’s first cryoballoon indicated for the treatment of paroxysmal atrial fibrillation (PAF) is building upon the proven safety and efficacy of the original Arctic Front Cryoballoon. The original Arctic Front product has a low complication risk and a proven efficacy in treating atrial fibrillation (AF). Over 35,000 patients in more than 400 centers worldwide have been treated with Arctic Front.